Senseonics Holdings Inc (NYSE American:SENS)

1.95
Delayed Data
As of Aug 08
 -0.16 / -7.58%
Today’s Change
0.77
Today|||52-Week Range
4.28
-26.97%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Electronic Components
MARKET CAP
$970.5M

Company Description

Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a glucose monitoring device which includes sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Contact Information

Senseonics Holdings, Inc.
20451 Seneca Meadows Parkway
Germantown Maryland 20876-7005
P:(301) 515-7260
Investor Relations:

Employees

Shareholders

Mutual fund holders14.21%
Individual stakeholders11.79%
Other institutional10.19%

Top Executives

Timothy T. GoodnowPresident, Chief Executive Officer & Director
Mukul JainChief Operating Officer
Nick B TresslerSecretary, Chief Financial & Accounting Officer
Francine R. KaufmanDirector & Chief Medical Officer
Mirasol G. PanlilioVice President & GM-Global Commercial Operations